Acutaas Chemicals P/B Ratio
Acutaas Chemicals (ACUTAAS) P/B ratio is 13.68 (High), book value per share ₹321.95 vs Healthcare average P/B of -0.99 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see ACUTAAS stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ACUTAAS P/B Ratio — Valuation Insights & Book Value Analysis
Acutaas Chemicals price-to-book ratio interpretation, valuation status and historical context — current P/B 13.68 (High). Check ACUTAAS market value to track the company's total market size over time.
- Stock appears overvalued with PB of 13.68, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 143.5% above historical average
- Trading at premium to sector average PB of -0.99
Acutaas Chemicals P/B Ratio Historical Trend
ACUTAAS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore ACUTAAS share price charts to track price trends across different timeframes.
ACUTAAS Historical P/B Ratio — Book Value Per Share & Year-End Price
Acutaas Chemicals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.3 | ₹321.95 | ₹1704.90 | ₹1,320 | High |
| 2024 | 5.82 | ₹184.59 | ₹1074.40 | ₹683 | High |
| 2023 | 3.4 | ₹165.0 | ₹561.00 | ₹594 | High |
| 2022 | 3.33 | ₹145.0 | ₹482.70 | ₹522 | High |
| 2021 | 10.24 | ₹52.19 | ₹534.20 | ₹167 | High |
ACUTAAS vs Healthcare Peers — P/B Ratio Comparison
Acutaas Chemicals P/B 13.68 vs Healthcare average -0.99, median 0.6 — range -36.63–1.06.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.07 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |